Here are relevant reports on : industrial-balloon-market
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029
The global peripheral vascular devices market, valued at US$10.94 billion in 2023, stood at US$11.43 billion in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$14.73 billion by the end of the period. Several factors drive growth in this peripheral vascular devices market. A pertinent factor is the incidence of peripheral artery disease and other vascular diseases, which is rising, primarily because of an aging population but also due to risk factors such as diabetes, hypertension, and obesity.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
North America Weight Loss /Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] – Forecasts to 2017
Obesity and weight gain have always been major concerns regarding the health and fitness of individuals; today, it has reached the level of an epidemic. Increasing obesity rate and increasing levels of awareness amongst calorie-conscious consumers in North America have opened new avenues for the weight management industry.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030
The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027
The global sinus dilation devices market growth is primed to transition from USD 2.8 billion in 2022 to USD 3.8 billion by 2027, showcasing a strong CAGR of 6.6%. The expansion of this market is due in large part to the upsurge in cases of chronic sinusitis as well as growing healthcare spending. However, a lack of skilled ENT professionals is one of the challenges that may inhibit the growth of this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
PTA Balloon Catheter Market by Type (Polyurethane, Nylon), Application (Coronary Artery Disease, Peripheral Vascular Disease), End User (Hospitals, Ambulatory Surgical Centers), and Geography -Forecast to 2027
The global PTA balloon catheter market size is estimated to be valued at ~USD 1.8 Billion in 2021 and is expected to grow at a CAGR of 7.1% during the forecast period (2022-2027). The market is driven by factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence f peripheral vascular diseases and coronary artery diseases, favorable reimbursement scenarios for peripheral vascular and coronary artery procedures, increased number of product approvals, increase the prevalence of diabetes, the rising rate of tobacco consumption, and growth in the incidences of obesity. On the other hand, a rise in the availability of alternative treatments, and a dearth of skilled professionals wth expertise in peripheral vascular devices, are expected to limit market growth to a certain extent in the coming years.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Vascular Stent Market by Technology (Drug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029
The global vascular stents market, valued at US$10.7 billion in 2023, stood at US$11.4 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$15.6 billion by the end of the period. The growth of the vascular stents market is primarily attributed to the increasing incidence of vascular diseases (such as coronary artery diseases, peripheral artery diseases, and endovascular aortic aneurysms) and the rising uptake of angioplasty procedures.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Abdominal Aortic Aneurysm Repair Market by Product (Stent Graft, Synthetic Stent Graft, Catheter, Guidewire, Vascular Closure Devices, Balloon Inflation Devices), Site (Intrarenal, Para renal (Juxta renal, Suprarenal)) Global Forecast to 2023
The global abdominal aortic aneurysm repair (AAA) market is expected to reach USD 2.40 billion in 2023 from USD 1.64 billion in 2018, growing at a CAGR of 7.9%. Increasing prevalence of atherosclerosis, syphilis and medical cystic necrosis; and rising geriatric population are the major driving factors for this market. In addition to this, technological advancements in the medical devices, availability of reimbursement for medical devices and treatment are other supporting factors for this market. However, entry barriers to new players; and stringent government regulations.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clot Management Market by Product [Percutaneous Thrombectomy (Mechanical, Aspiration), Embolectomy Balloon, CDT, Inferior Vena Cava Filter (Permanent, Retrievable), & Neurovascular Embolectomy] & End User (Hospital, Diagnostic) - Global Forecasts to 2019
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecasts to 2023
The global occlusion devices market is projected to reach USD 3.55 Billion by 2023, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).
- Published: April 2018
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
